Pure Global

IVD Department quantitative antibody test for Thyroglobulin - Vietnam Registration 240000712/PCBB-HCM

Access comprehensive regulatory information for IVD Department quantitative antibody test for Thyroglobulin in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại B medical device is registered under number 240000712/PCBB-HCM and manufactured by Beckman Coulter, Inc.. The authorized representative in Vietnam is VĂN PHÒNG ĐẠI DIỆN BECKMAN COULTER HONG KONG LIMITED TẠI TPHCM.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
240000712/PCBB-HCM
Registration Details
Vietnam MOH Registration: 240000712/PCBB-HCM
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

IVD Department quantitative antibody test for Thyroglobulin
VN: Bộ IVD xét nghiệm định lượng kháng thể kháng Thyroglobulin
Risk Class TTBYT Loại B

Registration Details

240000712/PCBB-HCM

000.00.19.H29-240111-0029

Theo theo phụ lục

Theo phụ lục

Company Information

Theo theo phụ lục

Beckman Coulter, Inc.

Technical Details

1/ The quantitative antibody test for Thyroglobulin (Type: ACCESS THYROGLOBULIN ANTIBODY II / Product Code: C86552): It is a fluorescent chemiluminescence, particle-enhanced immunoassay for the quantitative determination of thyroglobulin antibodies in human serum and plasma using the Access Immunoassay Systems. The measured value of the thyroglobulin autoantibody can support the diagnosis of Hashimoto's disease, non-toxic goiter, and Graves' disease. 2/ The quantitative antibody test for Thyroglobulin (Type: ACCESS THYROGLOBULIN ANTIBODY II CALIBRATORS / Product Code: A36920): It is used to calibrate the Access Thyroglobulin II antibody test for the quantitative determination of thyroglobulin antibodies in human serum and plasma using the Access Immunoassay Systems.

Dates and Status

Apr 04, 2024